The R&D expense increase rate of pharmaceutical companies in KOSPI was 3 times higher than the one for the KOSDAQ
It was estimated that R&D expenses of KOSPI and KODAQ listed pharmaceutical companies increased respective 16.5% and 5.4% up in the first half compared to the same half of the year.
Pharmaceutical companies listed in the KOSPI = According to the YakupDotCom’s(www.yakup.com) analysis result for t...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
